US Stock MarketDetailed Quotes

TMCI Treace Medical Concepts

Watchlist
  • 10.080
  • 0.0000.00%
Close Feb 14 16:00 ET
627.95MMarket Cap-10.18P/E (TTM)

About Treace Medical Concepts Company

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Company Profile

SymbolTMCI
Company NameTreace Medical Concepts
Listing DateApr 23, 2021
Issue Price17.00
Founded2013
CEOMr. John T. Treace
MarketNASDAQ
Employees516
Fiscal Year Ends12-31
Address100 Palmetto Park Place
CityPonte Vedra Beach
ProvinceFlorida
CountryUnited States of America
Zip Code32081
Phone1-904-373-5940

Company Executives

  • Name
  • Position
  • Salary
  • John T. Treace
  • Chief Executive Officer and Director
  • --
  • Scot Michael Elder
  • Corporate Secretary, Chief Legal and Compliance Officer
  • --
  • Mark L. Hair
  • Chief Financial Officer and Principal Accounting Officer
  • 4.69M
  • Sean F. Scanlan, PhD
  • Chief Innovation Officer
  • --
  • Aaron J. Berutti
  • Senior Vice President, Sales
  • 3.26M
  • James T. Treace
  • Chairman of the Board
  • 94.74K
  • Deepti Jain
  • Independent Director
  • 209.79K
  • Elizabeth S. Hanna
  • Independent Director
  • 202.26K
  • Richard W. Mott
  • Independent Director
  • 197.26K
  • John K. Bakewell
  • Independent Director
  • 214.79K
  • Jane E. Kiernan
  • Independent Director
  • 197.26K
  • Lawrence W. Hamilton
  • Independent Director
  • 214.79K
  • Lance A. Berry, C.P.A.
  • Independent Director
  • 199.79K

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More